Cargando…

Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure

Case series Patients: Male, 63-year-old • Female, 72-year-old • Female, 55-year-old Final Diagnosis: Amyloid light-chain amyloidosis • cardiac amyloidosis • cardiomyopathy • heart failure • primary AL amyloidosis Symptoms: Aphasia • dyspnea • heart failure • thrombosis • tongue mass Medication: — Cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roginić, Siniša, Vinter, Ozren, Trbušić, Matias, Roginić, Martina, Ćuti, Edina Ćatić
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669957/ https://www.ncbi.nlm.nih.gov/pubmed/33175723 http://dx.doi.org/10.12659/AJCR.926290

Ejemplares similares

NOMOGRAM CONTAINING SIMPLE ROUTINE CLINICAL AND BIOCHEMICAL PARAMETERS CAN PREDICT PATHOLOGIC VENTRICULAR REMODELING IN STEMI PATIENTS
por: Vinter, Ozren, et al.
Publicado: (2021)

Erratum to: 12th WINFOCUS world congress on ultrasound in emergency and critical care
por: Ćuti, Edina Ćatić, et al.
Publicado: (2016)

Prevalence of multiple sclerosis in Croatia: data from national and non-governmental organization registries
por: Benjak, Tomislav, et al.
Publicado: (2018)

Suspecting Cardiac Amyloidosis in Congestive Heart Failure
por: Alatassi, Emad U, et al.
Publicado: (2020)

Cardiac amyloidosis—an underdiagnosed cause of heart failure in the elderly
por: Nazir, Tahir, et al.
Publicado: (2020)

Cardiac Amyloidosis Presenting as Biventricular Systolic Heart Failure
por: Oye, Monique, et al.
Publicado: (2021)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
por: Molina O, Gabriela, et al.
Publicado: (2014)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Diagnosing Cardiac Amyloidosis: From Heart Failure to Electrical Storm
por: Mathews, Adithya T., et al.
Publicado: (2021)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients
por: Potočnjak, Ines, et al.
Publicado: (2017)

Atrial fibrillation in patients with cardiac amyloidosis and heart failure: a desperate cause?
por: Sellal, Jean-Marc, et al.
Publicado: (2023)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients
por: Potočnjak, Ines, et al.
Publicado: (2018)

Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases
por: Degoricija, Vesna, et al.
Publicado: (2018)

Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis
por: Ladefoged, Bertil Thyrsted, et al.
Publicado: (2022)

Author Correction: Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases
por: Degoricija, Vesna, et al.
Publicado: (2019)

CHOLESTEROL AND CHLORIDE IN ACUTE HEART FAILURE
por: Radulović, Bojana, et al.
Publicado: (2019)

Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic
por: Lindmark, Krister, et al.
Publicado: (2020)

Cardiac amyloidosis as a rare cause of heart failure: A case report
por: Gao, Ming, et al.
Publicado: (2019)

Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
por: Okamoto, Nao, et al.
Publicado: (2019)

Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis
por: Bosah, Arinze N, et al.
Publicado: (2022)

Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
por: Jonker, Daphne L., et al.
Publicado: (2018)

Imaging cardiac innervation in amyloidosis
por: Slart, Riemer H. J. A., et al.
Publicado: (2017)

Cardiac Amyloidosis: Updates in Imaging
por: Chacko, Liza, et al.
Publicado: (2019)

Advanced Imaging in Cardiac Amyloidosis
por: Waldmeier, Dominik, et al.
Publicado: (2022)

Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients
por: Potočnjak, Ines, et al.
Publicado: (2016)

Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis
por: Izumida, Toshihide, et al.
Publicado: (2021)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2017)

Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis
por: Michels da Silva, Diana, et al.
Publicado: (2019)

Cardiac amyloidosis—An underdiagnosed cause of heart failure: A case report and review of literature
por: Parmar, Kanak, et al.
Publicado: (2022)

Persistent Heart Failure Despite Medical Therapy Leading to a Diagnosis of Cardiac Amyloidosis
por: Maraj, Diva, et al.
Publicado: (2023)

Intracardiac Thrombosis and Heart Failure in a Patient with Hepatocellular Carcinoma and Cardiac Amyloidosis and an Implanted Cardiac Resynchronization Therapy Device
por: Akutsu, Yasushi, et al.
Publicado: (2019)

Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients
por: Degoricija, Vesna, et al.
Publicado: (2019)

Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure—Barriers and Opportunities for Improvement: The PREVAMIC Study
por: Ruiz-Hueso, Rocío, et al.
Publicado: (2023)

Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure
por: Berthelot, Emmanuelle, et al.
Publicado: (2023)

HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients
por: Klobučar, Iva, et al.
Publicado: (2022)

Bone scintigraphy imaging of cardiac amyloidosis
por: Kuria, Issa Menge, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q67td4ccvda1rdt7dqg0k1abdn